Financial Information

Financial

Information

Investor Resources

FY23 Annual Report

View / Download

FY22 Annual Report

View / Download

FY21 Annual Report

View / Download

FY20 Annual Report

View / Download

FY19 Annual Report

View / Download

FY18 Annual Report

View / Download

FY23 Annual Report

FY22 Annual Report

FY21 Annual Report

FY20 Annual Report

FY19 Annual Report

FY18 Annual Report

FY17 Annual Report

FY16 Annual Report

FY15 Annual Report

FY14 Annual Report

FY13 Annual Report

CEO's Desk

We believe that we are BIG enough to create a positive impact for patients and healthcare providers, yet small enough to still care.

Q3 FY24 Results Sheet

View / Download

Q2 FY24 Results Sheet

View / Download

Q1 FY24 Results Sheet

View / Download

Q4 FY23 Results Sheet

View / Download

Q3 FY23 Results Sheet

View / Download

Q2 FY23 Results Sheet

View / Download

Shareholder's corner

CEO's Desk

We believe that we are BIG enough to create a positive impact for patients and healthcare providers, yet small enough to still care.

Q3 FY24 Investor Presentation

View / Download

Investor Presentation – Entry into ophthalmology brands

View / Download

Q2 FY24 Investor Presentation

View / Download

Q1 FY24 Investor Presentation

View / Download

Q4 FY23 Investor Presentation

View / Download

Q3 FY23 Investor Presentation

View / Download

Shareholder's corner

CEO's Desk

We believe that we are BIG enough to create a positive impact for patients and healthcare providers, yet small enough to still care.

Q3 FY24 Press Release

View / Download

Q2 FY24 Press Release

View / Download

Q1 FY24 Press Release

View / Download

Q4 FY23 Press Release / News

View / Download

Q3 FY23 Press Release / News

View / Download

Press Release in relation to acquisition of ‘Razel’ franchise from Glenmark Pharmaceuticals Limited

View / Download

Shareholder's corner

CEO's Desk

We believe that we are BIG enough to create a positive impact for patients and healthcare providers, yet small enough to still care.

Q3 FY24 Earnings Call Audio

View / Download

Entry into ophthalmology brands

View / Download

Q2 FY24 Earnings Call Audio

View / Download

Q1 FY24 Earnings Call Audio

View / Download

Q4 FY23 Earnings Call Audio

View / Download

Q3 FY23 Earnings Call Audio

View / Download

Shareholder's corner

CEO's Desk

We believe that we are BIG enough to create a positive impact for patients and healthcare providers, yet small enough to still care.

Q3 FY 24 Earnings Call Transcript

View / Download

Earnings Call Transcript – Entry into Ophthalmology segment

View / Download

Q2 FY 24 Earnings Call Transcript

View / Download

Q1 FY 24 Earnings Call Transcript

View / Download

Q4 FY 23 Earnings Call Transcript

View / Download

Q3 FY 23 Earnings Call Transcript

View / Download

Shareholder's corner

CEO's Desk

We believe that we are BIG enough to create a positive impact for patients and healthcare providers, yet small enough to still care.

IR & Shareholder Contact

For Shareholders:
Mr. Sandeep Phadnis
Cnergy IT Park, Unit A2, 3rd floor, Appa Saheb Marathe Marg, Prabhadevi, Mumbai 400025. India.

Tel No. 91-22-2439 5200 / 2439 5500
Fax No. 91-22-2431 5331 / 2431 5334

Email: sandeep.phadnis@jbpharma.com

For transfer/transmission of shares:
Datamatics Business Solutions Ltd. Plot No. B 5, Part B Crosslane, MIDC, Andheri (East), Mumbai SE” 400 093

Contact Person: Mr. Satish Patil
Tel No: (022) 6671 2001-06
Fax No. (022) 6671 2011

Email: investorquery@datamaticsbpm.com

Nodal Officer for the purpose of coordination with IEPF authority:
Mr. Sandeep Phadnis
Cnergy IT Park, Unit A2, 3rd floor, Appa Saheb Marathe Marg, Prabhadevi, Mumbai 400 025. India.

Tel No. 91-22-2439 5200/ 2439 5500
Fax No. 91-22-2431 5331 / 2431 5334

Email: sandeep.phadnis@jbpharma.com